BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1453825)

  • 1. [Pharmaceutic promotion and publicity: quo vadis?].
    Castillo Pérez P
    Med Clin (Barc); 1992 Sep; 99(8):305-9. PubMed ID: 1453825
    [No Abstract]   [Full Text] [Related]  

  • 2. PharmAid.
    Kimball-Baker K
    Healthc Inform; 1998 Jul; 15(7):48-52, 54, 56. PubMed ID: 10181187
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug advertising.
    Med J Aust; 1987 Jun; 146(12):660-1. PubMed ID: 3626920
    [No Abstract]   [Full Text] [Related]  

  • 4. Questions timing of publicity on new drug.
    Dorsey M
    J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical promotion.
    Harvey K
    Med J Aust; 1990 Jan; 152(2):57-8. PubMed ID: 2296230
    [No Abstract]   [Full Text] [Related]  

  • 6. The Food and Drug Administration's regulation of drug labeling, advertising, and promotion: looking back and looking ahead.
    Hayes TA
    Clin Pharmacol Ther; 1998 Jun; 63(6):607-16. PubMed ID: 9663174
    [No Abstract]   [Full Text] [Related]  

  • 7. [On ethical issues of pharmaceutical communication. National Association of Hungarian Pharmaceutical Manufacturers and Wholesalers].
    Kata M; Sánta Z
    Orv Hetil; 1994 Oct; 135(42):2343-7. PubMed ID: 7970650
    [No Abstract]   [Full Text] [Related]  

  • 8. "Ethical" drugs.
    Rivin AU
    Pharos Alpha Omega Alpha Honor Med Soc; 1980; 43(2):9-10. PubMed ID: 7384207
    [No Abstract]   [Full Text] [Related]  

  • 9. The new frontier for pharmacy automation.
    Burke M
    Health Data Manag; 1994 Nov; 2(9):48-50, 52, 54-5. PubMed ID: 10141052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug advertising.
    Moulds RF; Wing LM
    Med J Aust; 1989 Apr; 150(7):410-1. PubMed ID: 2716670
    [No Abstract]   [Full Text] [Related]  

  • 11. [An analysis of drug advertising in non-specialty medical journals].
    López Valpuesta FJ; Hevia Alonso A; Vázquez Díaz JA; Fernández López JA; Fernández Alonso A
    Rev Clin Esp; 1993 Feb; 192(3):130-3. PubMed ID: 8465049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of pharmaceutical advertising. A look at medical journals reveals a new era in advertising.
    Weeks WB; Wallace AE; Kimberly BC
    Mark Health Serv; 2001; 21(3):27-30. PubMed ID: 11525138
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Assessment of advertising.
    Wigle WW
    Can Med Assoc J; 1974 Apr; 110(7):759. PubMed ID: 4825144
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug promotion and doctor: a relationship under change?
    Bhatt AD
    J Postgrad Med; 1993; 39(3):120-3. PubMed ID: 8051638
    [No Abstract]   [Full Text] [Related]  

  • 15. Student rally. Med school attendees write ethics code on drug firms.
    Romano M
    Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
    [No Abstract]   [Full Text] [Related]  

  • 16. Sharing strategic information.
    Navarro RP
    Manag Care Interface; 1998 Jun; 11(6):61-3. PubMed ID: 10181560
    [No Abstract]   [Full Text] [Related]  

  • 17. Can drug companies have it both ways?
    Rapp MS
    CMAJ; 1997 Apr; 156(7):982-3. PubMed ID: 9099165
    [No Abstract]   [Full Text] [Related]  

  • 18. Code of fair practices in the promotion of drug products.
    Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133
    [No Abstract]   [Full Text] [Related]  

  • 19. US drug industry's guidelines on advertising too limited, say critics.
    Burton B
    BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059
    [No Abstract]   [Full Text] [Related]  

  • 20. PAAB: a lesson in self-government.
    Lexchin J
    CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.